Cargando…

Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use

One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiayu, Fitaihi, Rawan, Abukhamees, Shorooq, Abdelhakim, Hend E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860831/
https://www.ncbi.nlm.nih.gov/pubmed/36678881
http://dx.doi.org/10.3390/pharmaceutics15010250
_version_ 1784874688116162560
author Hu, Jiayu
Fitaihi, Rawan
Abukhamees, Shorooq
Abdelhakim, Hend E.
author_facet Hu, Jiayu
Fitaihi, Rawan
Abukhamees, Shorooq
Abdelhakim, Hend E.
author_sort Hu, Jiayu
collection PubMed
description One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (CBZ). This dosage form was prepared and 3D-printed via a semi-solid extrusion technique. Design of Experiment methods were applied for optimising the formulation. The formulation with 40% (w/w) of SSG (superdisintegrant) and 5% (w/w) of PVP K30 (binder) was selected and loaded with CBZ. The drug-loaded tablets were characterised by a mean hardness of 18.5 N and a disintegrating time of 84 s, along with acceptable friability. The mean drug loading ratio of the tablets was tested as 90.56%, and the drug release rate in 0.1 M HCl reached 68.3% at 45 min. Excipients showed proper compatibility with the drug in physical form analysis. Taste assessment via an E-tongue was also conducted, where the drug did not show bitter taste signals at a low concentration in the taste assessment, and the sweetener also blocked bitterness signals in the testing. To this end, ODMTs were found to be potential candidates for child-appropriate dosage forms delivering CBZ.
format Online
Article
Text
id pubmed-9860831
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98608312023-01-22 Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use Hu, Jiayu Fitaihi, Rawan Abukhamees, Shorooq Abdelhakim, Hend E. Pharmaceutics Article One of the main challenges to paediatric drug administration is swallowing difficulties, hindering the acceptability of the medicine and hence clinical outcomes. This study aims at developing a child-appropriate dosage form, the orodispersible mini-tablet (ODMT), using the model drug carbamazepine (CBZ). This dosage form was prepared and 3D-printed via a semi-solid extrusion technique. Design of Experiment methods were applied for optimising the formulation. The formulation with 40% (w/w) of SSG (superdisintegrant) and 5% (w/w) of PVP K30 (binder) was selected and loaded with CBZ. The drug-loaded tablets were characterised by a mean hardness of 18.5 N and a disintegrating time of 84 s, along with acceptable friability. The mean drug loading ratio of the tablets was tested as 90.56%, and the drug release rate in 0.1 M HCl reached 68.3% at 45 min. Excipients showed proper compatibility with the drug in physical form analysis. Taste assessment via an E-tongue was also conducted, where the drug did not show bitter taste signals at a low concentration in the taste assessment, and the sweetener also blocked bitterness signals in the testing. To this end, ODMTs were found to be potential candidates for child-appropriate dosage forms delivering CBZ. MDPI 2023-01-11 /pmc/articles/PMC9860831/ /pubmed/36678881 http://dx.doi.org/10.3390/pharmaceutics15010250 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hu, Jiayu
Fitaihi, Rawan
Abukhamees, Shorooq
Abdelhakim, Hend E.
Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title_full Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title_fullStr Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title_full_unstemmed Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title_short Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
title_sort formulation and characterisation of carbamazepine orodispersible 3d-printed mini-tablets for paediatric use
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860831/
https://www.ncbi.nlm.nih.gov/pubmed/36678881
http://dx.doi.org/10.3390/pharmaceutics15010250
work_keys_str_mv AT hujiayu formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse
AT fitaihirawan formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse
AT abukhameesshorooq formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse
AT abdelhakimhende formulationandcharacterisationofcarbamazepineorodispersible3dprintedminitabletsforpaediatricuse